News

CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of Nephrology

BERKELEY HEIGHTS, N.J., Sept. 08, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…

11 months ago

Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Acquisition Strategy Differentiates Company in Projected $51B Global Cannabis Market

NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) -- via IBN — Lucy Scientific Discovery Inc. (NASDAQ: LSDI) today announces its placement in…

11 months ago

Elutia to Present at the H.C. Wainwright 25th Annual Global Investment Conference

SILVER SPRING, Md., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a company pioneering drug-eluting biomatrix products,…

11 months ago

Spectral Medical Featured in New Episode of ‘The Balancing Act’ Airing on Lifetime TV Focused on Endotoxic Septic Shock

Episode to be Broadcast on Monday, September 11th and Tuesday, September 19th 2023 at 7:30 a.m. (ET/PT) TORONTO, Sept. 08,…

11 months ago

Polarean Partners with VIDA to Streamline Adoption of Advanced MRI of the Lungs

Two best-in-class lung imaging companies combine expertise for the deployment of a new xenon 129 MRI platform.Durham, NC and London,…

11 months ago

Singular Genomics to Present at the Gilmartin Group Emerging Growth Company Showcase

SAN DIEGO, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing…

11 months ago

Positron Corporation Announces Start of Clinical Study of Affinity PET-CT Device

Niagara Falls, NY, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular…

11 months ago

Ardelyx to Present at the H.C. Wainwright 25th Annual Global Investment Conference

WALTHAM, Mass., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to…

11 months ago

Rhythm Pharmaceuticals Announces Update to September Conference Participation

BOSTON, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the…

11 months ago